Evaluating Concomitant Use of Very Low Nicotine Content Cigarettes and E-cigarettes Among Daily and Non-Daily Smokers on Abuse Liability

评估日常和非日常吸烟者同时使用尼古丁含量极低的香烟和电子烟的滥用责任

• 批准号: 9193508
• 负责人: PAUL MICHAEL CINCIRIPINI
• 金额: $ 81.39万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-15 至 2019-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9193508
• 关键词: Address; Adult; Affect; Alkaloids; Anabasine; Attitude; Back; Cellular Phone; Cessation of life; Cigarette; Complement; Disease; Dose; Electronic cigarette; Environment; Equilibrium; Exposure to; Family Smoking Prevention and Tobacco Control Act; Financial compensation; Health Benefit; Intention; Lead; Marketing; Measurement; Measures; Minor; Modeling; Nicotine; Nicotine Dependence; Participant; Patients; Phase; Prevalence; Psychological reinforcement; Public Health; Questionnaires; Reporting; Research; Smoke; Smoker; Smoking; Smoking Behavior; Source; Time; Tobacco; Withdrawal; authority; base; craving; design; diaries; indexing; meetings; negative affect; nicotine abuse; nornicotine; satisfaction; tobacco advertising; toxicant

PROJECT SUMMARY/ABSTRACT The Family Smoking Prevention and Tobacco Control Act (FSPTCA) provides the FDA with authority to limit the nicotine content of cigarettes, which could reduce cigarette reinforcement and lead to less nicotine addiction and exposure to harmful toxicants associated with tobacco combustion. Recently, the FDA announced its intention to regulate the e-cigarettes (e-cig). We have very little information on how such changes in the tobacco market place, specifically e-cigarettes, will affect nicotine abuse liability. The objective of this study is to model abuse liability in a market in which the level of nicotine in combustible cigarettes has been lowered to meet a potential regulatory standard, but one in which an alternate source of nicotine in e-cigs is also available. Aims 1 and 2 will characterize the effects of dual use of VLNCC and ECIG on abuse liability (nicotine compensation and product use, liking, and RRE) among daily (DS) and intermittent (ITS) smokers, respectively. Aim 3 will characterize the effects of dual product use on abuse liability, as measured by retrospective measures, smartphone daily diary, and real-time measures captured using smartphone EMA. Participants will be 80 daily (DS) and 80 intermittent (ITS) non-treatment-seeking adult smokers who are not regular e-cig users. Participants will smoke their usual brand (UB) during Phase 1 (Baseline; week 1) and will exclusively smoke the VLNCC during Phase 2 (weeks 2-4). During phases 3 (weeks 5-7) & 4 (weeks 8-10), smokers will be instructed to freely use any combination of assigned VLNCC and e-cigs (VLNCC+ECIG). All subjects will receive both e-cig doses (ECIG-Hi (36 mg/ml) and ECIG-Lo (8 mg/ml)) with order counter balanced across phases 3 and 4. The significance of this proposal is that it will provide the FDA with critical information about the effects of dual use of very low nicotine content cigarettes (VLNCC) and e-cigs with differing levels of nicotine on nicotine abuse liability, as measured by nicotine compensation, product use and liking, relative reinforcing efficacy (RRE), and multi-modal assessments of withdrawal, craving, affect and satisfaction, among both daily (DS) and intermittent (ITS) smokers in the lab and in their natural environment. The coexistence of these products raises questions about whether the potential public health benefit of VLNCC at reducing nicotine abuse liability might be offset by the concurrent use of e-cigs. The positive impact of this study will be to provide scientific information on the nicotine abuse liability impact of reducing nicotine in combustible cigarettes to a non-reinforcing level within a dual product use environment, which can be used to inform tobacco regulatory strategies designed to promote the public health. The innovativeness of this study is our focus on the nicotine abuse liability of dual use by both DS and ITS, and our use of a multimodal approach to the measurement of abuse liability constructs, including the use of EMA, given that little is known about the effects of dual use on these abuse liability constructs in the natural environment. The value-added feature of this study is that it complements and extends findings from existing TCORS involving VLNC and e-cigarettes.

项目总结/摘要 《家庭吸烟预防和烟草控制法》（FSPTCA）授权FDA 限制香烟中的尼古丁含量，这可能会减少香烟的强化作用，导致尼古丁含量减少 成瘾和接触与烟草燃烧有关的有害有毒物质。最近，FDA 宣布打算对电子烟（e-cig）进行监管。我们对这种情况如何发生知之甚少， 烟草市场的变化，特别是电子烟，将影响尼古丁滥用倾向。客观 这项研究的目的是模拟市场中的滥用倾向，其中可燃香烟中的尼古丁水平 已经降低，以满足潜在的监管标准，但其中电子烟中尼古丁的替代来源 完美的享受放松目标1和2将描述VLNCC和ECIG双重使用对滥用责任的影响 （尼古丁补偿和产品使用，喜好和RRE）在每日（DS）和间歇性（ITS）吸烟者中， 分别目标3将描述双重产品使用对滥用责任的影响， 回顾性测量、智能手机每日日志和使用智能手机EMA捕获的实时测量。 受试者将为80名每日（DS）和80名间歇（ITS）非寻求治疗的成年吸烟者， 电子烟的常客受试者将在第1阶段（基线;第1周）期间吸烟其常用品牌（UB），并将 在第2阶段（第2-4周）专门吸烟VLNCC。在阶段3（第5-7周）和阶段4（第8-10周）期间， 吸烟者将被指示自由使用分配的VLNCC和电子烟的任何组合（VLNCC+ECIG）。所有 受试者将接受两种电子烟剂量（ECIG-Hi（36 mg/ml）和ECIG-Lo（8 mg/ml）），并配有订购计数器 在第三阶段和第四阶段平衡。该提案的重要性在于，它将为FDA提供关键的 关于极低尼古丁含量香烟（VLNCC）和电子烟双重使用的影响的信息， 不同水平的尼古丁对尼古丁滥用倾向的影响，通过尼古丁补偿、产品使用和 喜欢，相对强化效率（RRE），以及对戒断，渴望，影响和 在实验室和自然环境中，每日（DS）和间歇性（ITS）吸烟者的满意度。 这些产品的共存提出了一个问题，即VLNCC的潜在公共卫生益处是否 同时使用电子烟可能会抵消减少尼古丁滥用的责任。这种积极的影响 研究将提供有关减少尼古丁对尼古丁滥用倾向影响的科学信息， 在双重产品使用环境中，将可燃香烟降低到非增强水平，其可用于 为旨在促进公共健康的烟草管制战略提供信息。本研究的创新之处在于 我们关注DS和ITS双重使用的尼古丁滥用倾向，以及我们使用的多模式方法 滥用责任结构的测量，包括EMA的使用，鉴于对 双重用途对自然环境中这些滥用责任结构的影响。的增值功能 这项研究补充和扩展了现有的涉及VLNC和电子烟的TCORS的发现。